Arthur Truslove analyst CITI

Currently out of the existing stock ratings of Arthur Truslove, 6 are a BUY (85.71%), 1 are a HOLD (14.29%).

Arthur Truslove

Work Performance Price Targets & Ratings Chart

Analyst Arthur Truslove, currently employed at CITI, carries an average stock price target met ratio of 87.5% that have a potential upside of 11.29% achieved within 138 days.

Arthur Truslove’s has documented 14 price targets and ratings displayed on 2 stocks. The coverage is on the Industrials sector.

Most recent stock forecast was given on EFX, Equifax at 11-Oct-2024.

Wall Street Analyst Arthur Truslove

Analyst best performing recommendations are on EXPGY (EXPERIAN PLC PK).
The best stock recommendation documented was for EXPGY (EXPERIAN PLC PK) at 5/20/2022. The price target of $32.98 was fulfilled within 7 days with a profit of $1.98 (6.39%) receiving and performance score of 9.12.

Average potential price target upside

EXPGY Experian plc PK EFX Equifax

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$30.4

$-18.27 (-37.54%)

$34.4

2 years 1 months 10 days ago
(12-Jan-2023)

5/5 (100%)

$-3.69 (-10.82%)

169

Buy

$39.28

$-9.39 (-19.29%)

$39.82

2 years 1 months 11 days ago
(11-Jan-2023)

11/11 (100%)

$4.97 (14.49%)

350

Buy

$32.58

$-17.15 (-34.49%)

$32.98

2 years 7 months 7 days ago
(15-Jul-2022)

3/3 (100%)

$0.44 (1.37%)

227

Buy

$40.84

$-8.89 (-17.88%)

$48.69

2 years 9 months 3 days ago
(19-May-2022)

2/2 (100%)

$10.49 (34.56%)

992

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Arthur Truslove is most bullish on?

Potential upside of $92.97 has been obtained for EFX (EQUIFAX)

What Year was the first public recommendation made by Arthur Truslove?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?